A new hub to support innovative AMR solutions for Biopharma Companies

17 novembre 2023
Non classifié(e)

S.O.L.V.E.- AMR – Solutions for Overcoming and Leveraging Versatile Efforts Against Microbial Resistance

[Lyon – Dijon – Paris, Tuesday October 10th, 2023] – BIOASTER, Cynbiose, ICTA, and PharmaLex announced today a strategic collaboration that aims to help combat antimicrobial resistance (AMR). As part of the initiative, the organizations will leverage their collective expertise and capabilities to offer innovative and integrated support from discovery, pre-clinical and clinical drug development processes up to registration and commercialization, helping to accelerate the development of antimicrobials. To know more